An Antihyperkinetic Action by the Serotonin 1A–Receptor Agonist Osemozotan Co-administered With Psychostimulants or the Non-stimulant Atomoxetine in Mice
It has been demonstrated that treatment of hyperactive mice with psychostimulants produced a calming effect depending on serotonergic neurotransmission. Our previous study also showed that hyperactivity in mice lacking pituitary adenylate cyclase–activating polypeptide (PACAP) was ameliorated by amp...
Main Authors: | Rie Tsuchida, Masahiro Kubo, Mariko Kuroda, Yasuhiro Shibasaki, Norihito Shintani, Michikazu Abe, Katalin Köves, Hitoshi Hashimoto, Akemichi Baba |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2009-01-01
|
Series: | Journal of Pharmacological Sciences |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1347861319312587 |
Similar Items
-
The Therapeutic Potential of Serotonin 1B Receptor Agonists for Treating Psychostimulant Use Disorders
Published: (2020) -
Differential Potency of Venlafaxine, Paroxetine, and Atomoxetine to Inhibit Serotonin and Norepinephrine Reuptake in Patients With Major Depressive Disorder
by: Aldosary, F., et al.
Published: (2022) -
Psychostimulant Drugs and Neuroplasticity
by: Emilio Fernandez-Espejo, et al.
Published: (2011-06-01) -
Psychostimulant toxicity in children
by: Ozalp Ekinci, et al.
Published: (2013-04-01) -
Psychostimulants and movement disorders.
by: Andres eAsser, et al.
Published: (2015-04-01)